Omeros Message Board - Msg: 31217385

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Omeros

OMER 7.330

-2.5%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Howard Williams	8/10/2017 8:52:16 AM
	of 464

Omeros to Present at the 2017 Wedbush PacGrow Healthcare Conference SEATTLE--(BUSINESS WIRE)--Aug. 10, 2017-- Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 2017 Wedbush PacGrow Healthcare Conference in New York next week. The presentation is scheduled for Tuesday, August 15, 2017 at 12:45 p.m. EDT. The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the company's website at www.omeros.com.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next